▶ SELANK · SUBTOPIC · MECHANISM
SELANK Mechanism
For Laboratory Research Use Only. The mechanistic information below is descriptive of published research. No human dose is recommended. No clinical claim is made.
MECHANISM OF ACTION
Synthetic heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro derived from tuftsin. Russian Academy of Sciences. Studied for GABAergic-pathway signaling and HPA-axis modulation.
PHARMACOKINETIC HALF-LIFE
Reported half-life for SELANK: Short (minutes) plasma; intranasal retention longer. Half-life determines the kinetic window across which receptor occupancy is maintained and frames the dosing rhythm used in published literature.
PRIMARY SEQUENCE
SELANK is a defined sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro. Synthesis proceeds via solid-phase peptide synthesis with HPLC-verified identity confirmation.
MECHANISM CATEGORIES
SELANK is tagged in 3 mechanism categories on GIGARESEARCH. Each category aggregates the broader pharmacology of related compounds.
Nootropic compounds act on canonical CNS pathways · BDNF / TrkB neurotrophic signaling, monoamine modulation, and GABAergic regulation. Russian-developed heptapeptides Semax and Selank are the most-studied research nootropics in the GigaCompounds catalog, both built on the same C-terminal Pro-Gly-Pro stabilizing strategy.
Anxiolytic peptides modulate the GABAergic system or HPA-axis stress response. Selank is the most-studied research anxiolytic peptide, with rodent EPM and conditioned-suppression data describing potency comparable to short-acting benzodiazepines at the doses tested, without direct GABA-A binding.
The GABAergic system is the dominant inhibitory neurotransmission pathway in the CNS, mediating anxiolysis, sedation, and seizure-threshold elevation. Selank modulates GABA-A receptor expression and binding affinity in cortical and hippocampal tissue, providing an indirect mechanism distinct from benzodiazepine direct agonism.
MECHANISTIC OUTCOMES IN LITERATURE
The following outcomes are the mechanistic endpoints reported in the peer-reviewed literature, with GIGARESEARCH evidence grades. Grades reflect study quality and replication, not clinical recommendation.
Kozlovskaya et al. multi-paper rodent EPM and conditioned-suppression data. Russian-language primary literature; subset Western-indexed.
Inozemtseva 2008 reported transient BDNF mRNA elevation. Limited replication outside Russian Academy of Sciences.
Russian clinical literature describes small open-label trials at 0.15% intranasal solution. No FDA or EMA Phase 3 trials.
MECHANISM Q+A
▶ Selank vs Semax · what's the difference?
Both are Russian-developed heptapeptides built on the same C-terminal Pro-Gly-Pro stabilizing strategy. Selank is derived from tuftsin (immunomodulatory parent). Semax is derived from the ACTH(4-10) fragment (neurotropic parent). Different mechanisms: Selank is studied for GABAergic anxiolytic pathways, Semax for BDNF-mediated cognitive pathways.
▶ How does Selank work?
Proposed mechanisms include modulation of GABA-A receptor expression and binding affinity in cortical and hippocampal tissue, increased serotonin (5-HT) turnover in rodent brain, and BDNF mRNA upregulation in selected forebrain regions. Selank also inherits some immunomodulatory activity from its tuftsin parent (macrophage and NK-cell activation).
▶ How does Selank compare to benzodiazepines?
Russian preclinical literature describes anxiolytic activity in rodent elevated-plus-maze and conditioned-suppression paradigms, with potency comparable to short-acting benzodiazepines at the doses tested. Without GABA-A direct binding, Selank theoretically lacks the dependence and withdrawal profile of benzodiazepines · though this is not validated by Western RCT.
CITED LITERATURE
- Kozlovskaya MM, Kozlovskii II, Val'dman EA, Seredenin SB. Selank and short peptides of the tuftsin family in the regulation of adaptive behavior in stress. Neurosci Behav Physiol 2003. link
- Vyunova TV, Andreeva LA, Shevchenko KV, Myasoedov NF. Synthetic Peptides as Promising Anxiolytics of New Generation: Experimental and Clinical Justification. Acta Naturae 2018. link
RELATED PAGES
▶ LAST UPDATED · 2026-05-19